PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 1382492-5 1992 After the addition of IFN-alpha, 17 of the 22 patients (77%) with elevated urinary 5-hydroxyindoleacetic acid showed a significant (> 50%) reduction. Hydroxyindoleacetic Acid 83-109 interferon alpha 1 Homo sapiens 22-31 1382492-9 1992 Thus, the addition of IFN-alpha is beneficial for patients with malignant carcinoid tumours that progress and/or who do not respond to octreotide. Octreotide 135-145 interferon alpha 1 Homo sapiens 22-31